Subscribe To

Price Alert Latest News Economic Calendar News

CC / The Chemours Company (CC) Q4 2022 Earnings Call Transcript

The Chemours Company (NYSE:CC ) Q4 2022 Results Earnings Conference Call February 10, 2023 8:00 AM ET Company Participants Jonathan Lock - Senior Vice President and Chief Development Officer Mark Newman - President and Chief Executive Officer Sameer Ralhan - Senior Vice President and Chief Financial Officer Conference Call Participants Duffy Fischer - Goldman Sachs Arun Viswanathan - RBC Capital Markets John McNulty - BMO Capital Markets Matthew DeYoe - Bank of America Securities Josh Spector - UBS Hassan Ahmed - Alembic Global Advisors Vincent Andrews - Morgan Stanley John Roberts - Credit Suisse Operator Good morning. My name is Rob and I will be your conference operator today. Read More

Demo Live Account See Partner Details

Content Topics

Chemours

Company

CC

2022

Earnings

Call

Transcript

Stock

Posted: Feb 10 2023, 14:11

Author Name: Seeking Alpha

CC News

By Seeking Alpha
October 27, 2023

The Chemours Company (CC) Q3 2023 Earnings Call Transcript

The Chemours Company (NYSE:CC ) Q3 2023 Earnings Conference Call October 27, 2023 8:00 AM ET Company Participants Brandon Ontjes - Vice President of F

By Zacks Investment Research
October 26, 2023

Compared to Estimates, Chemours (CC) Q3 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended September 2023, it could be w

By Zacks Investment Research
October 23, 2023

Why Chemours (CC) Could Beat Earnings Estimates Again

Chemours (CC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat i

By Business Wire
October 6, 2023

Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2023 Earnings Release and Webcast Conference Call.

By Zacks Investment Research
September 27, 2023

Here's Why You Should Hold Onto Chemours (CC) Stock For Now

Chemours (CC) gains on strong execution, continued Opteon adoption and its efforts to reduce costs amid headwinds from demand weakness.

By Reuters
September 27, 2023

Dutch court rules Chemours liable for environmental damage caused by PFAS

U.S. chemical company Chemours CC.N is liable for environmental damage in the Netherlands caused by PFAS chemicals, the Rotterdam District Court ruled

By Zacks Investment Research
August 31, 2023

Chemours (CC) Benefits From Opteon Adoption Amid Demand Woes

Although Chemours (CC) is being challenged by softer demand in certain businesses, it gains on continued Opteon adoption, strong execution and its cos

By Zacks Investment Research
August 22, 2023

Here's Why You Should Retain Chemours (CC) in Your Portfolio

While Chemours (CC) is exposed to headwinds from demand softness in certain areas, it gains on continued Opteon adoption, strong execution and its cos

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.